線維芽細胞増殖因子受容体1とは - わかりやすく解説 Weblio辞書

線維芽細胞増殖因子受容体1

出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2024/03/03 03:25 UTC 版)

線維芽細胞増殖因子受容体1（せんいがさいぼうぞうしょくいんしじゅようたい1、英: fibroblast growth factor receptor 1、略称: FGFR1）、またはCD331は、線維芽細胞増殖因子（FGF）ファミリーの特定のメンバーをリガンドとする、受容体型チロシンキナーゼである。FGFR1は、ファイファー症候群（英語版）^[5]、原発性好酸球増多症（英語版）^[6]との関連が示されている。

出典

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000077782 - Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000031565 - Ensembl, May 2017
^ Human PubMed Reference:
^ Mouse PubMed Reference:
^ “The complete amino acid sequence of the shorter form of human basic fibroblast growth factor receptor deduced from its cDNA”. Biochemical and Biophysical Research Communications 169 (2): 680–685. (June 1990). doi:10.1016/0006-291X(90)90384-Y. PMID 2162671.
^ “World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management”. American Journal of Hematology 90 (11): 1077–1089. (November 2015). doi:10.1002/ajh.24196. PMID 26486351.
^ “FGFR1 fibroblast growth factor receptor 1 [Homo sapiens (human)] - Gene - NCBI”. 2024年2月13日閲覧。
^ “Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform”. Fertility and Sterility 104 (5): 1261–7.e1. (November 2015). doi:10.1016/j.fertnstert.2015.07.1142. hdl:10400.17/2465. PMID 26277103.
^ ^a ^b ^c ^d ^e ^f ^g ^h ⁱ “FGF receptors: cancer biology and therapeutics”. Medicinal Research Reviews 34 (2): 280–300. (March 2014). doi:10.1002/med.21288. PMID 23696246.
^ ^a ^b ^c ^d ^e “Fibroblast growth factor receptors, developmental corruption and malignant disease”. Carcinogenesis 34 (10): 2198–2205. (October 2013). doi:10.1093/carcin/bgt254. PMID 23880303.
^ ^a ^b ^c ^d ^e ^f ^g “Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications”. Cancer and Metastasis Reviews 34 (3): 479–496. (September 2015). doi:10.1007/s10555-015-9579-8. PMC 4573649. PMID 26224133.
^ “Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development”. Developmental Biology 185 (1): 42–54. (May 1997). doi:10.1006/dbio.1997.8553. PMID 9169049.
^ “A missense mutation in Fgfr1 causes ear and skull defects in hush puppy mice”. Mammalian Genome 22 (5–6): 290–305. (June 2011). doi:10.1007/s00335-011-9324-8. PMC 3099004. PMID 21479780.
^ “OMIM Entry - * 136350 - FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1”. 2024年3月2日閲覧。
^ “FGFR1 Alterations”. 2015年4月27日時点のオリジナルよりアーカイブ。2015年4月21日閲覧。^{[要文献特定詳細情報]}
^ “Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer”. Journal of Clinical Oncology 31 (6): 731–737. (February 2013). doi:10.1200/JCO.2012.43.8622. PMID 23182986.
^ ^a ^b “Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1”. American Journal of Clinical Pathology 144 (3): 377–392. (September 2015). doi:10.1309/AJCPMORR5Z2IKCEM. PMID 26276769.
^ ^a ^b ^c ^d “Myeloid neoplasms with eosinophilia”. Blood 129 (6): 704–714. (February 2017). doi:10.1182/blood-2016-10-695973. PMID 28028030.
^ “Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies”. Critical Reviews in Oncology/Hematology 109: 20–34. (January 2017). doi:10.1016/j.critrevonc.2016.11.008. PMID 28010895.
^ ^a ^b “Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution”. American Journal of Hematology 85 (4): 238–242. (April 2010). doi:10.1002/ajh.21631. PMID 20143402.
^ “Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour”. The Journal of Pathology 235 (4): 539–545. (March 2015). doi:10.1002/path.4465. PMID 25319834.
^ “Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors”. Modern Pathology 29 (11): 1335–1346. (November 2016). doi:10.1038/modpathol.2016.137. PMID 27443518.
^ “FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes”. Genes, Chromosomes & Cancer 46 (11): 1028–1038. (November 2007). doi:10.1002/gcc.20489. PMID 17696196.
^ “FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma”. Modern Pathology 24 (10): 1327–1335. (October 2011). doi:10.1038/modpathol.2011.98. PMID 21666686.
^ “Transforming fusions of FGFR and TACC genes in human glioblastoma”. Science 337 (6099): 1231–1235. (September 2012). Bibcode: 2012Sci...337.1231S. doi:10.1126/science.1220834. PMC 3677224. PMID 22837387.
^ “Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer”. Journal of Oral Pathology & Medicine 45 (7): 500–509. (August 2016). doi:10.1111/jop.12394. PMID 26661925.
^ ^a ^b “Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer”. Clinical Cancer Research 19 (13): 3693–3702. (July 2013). doi:10.1158/1078-0432.CCR-13-0190. PMID 23658459.
^ “Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions”. Expert Review of Clinical Pharmacology 14 (10): 1233–1252. (October 2021). doi:10.1080/17512433.2021.1947246. PMID 34591728.
^ “Biological Significance and Targeting of the FGFR Axis in Cancer”. Cancers 13 (22): 5681. (November 2021). doi:10.3390/cancers13225681. PMC 8616401. PMID 34830836.
^ “Relapsed small cell lung cancer: treatment options and latest developments”. Therapeutic Advances in Medical Oncology 6 (2): 69–82. (March 2014). doi:10.1177/1758834013517413. PMC 3932054. PMID 24587832.
^ “A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel (P) in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification (amp): SHINE study.”. 2016年3月24日時点のオリジナルよりアーカイブ。2016年7月7日閲覧。
^ “Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors”. Annals of Oncology 25 (11): 2244–2251. (November 2014). doi:10.1093/annonc/mdu390. PMID 25193991.
^ “Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization”. Molecular Cell 6 (3): 743–750. (September 2000). doi:10.1016/s1097-2765(00)00073-3. PMID 11030354.
^ “Expression and biological activity of mouse fibroblast growth factor-9”. The Journal of Biological Chemistry 271 (3): 1726–1731. (January 1996). doi:10.1074/jbc.271.3.1726. PMID 8576175.
^ “FRS2 PTB domain conformation regulates interactions with divergent neurotrophic receptors”. The Journal of Biological Chemistry 277 (19): 17088–17094. (May 2002). doi:10.1074/jbc.M107963200. PMID 11877385.
^ “FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors”. Molecular and Cellular Biology 20 (3): 979–989. (February 2000). doi:10.1128/mcb.20.3.979-989.2000. PMC 85215. PMID 10629055.
^ “Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins”. The Journal of Biological Chemistry 273 (29): 17987–17990. (July 1998). doi:10.1074/jbc.273.29.17987. PMID 9660748.
^ “Structural basis of SNT PTB domain interactions with distinct neurotrophic receptors”. Molecular Cell 6 (4): 921–929. (October 2000). doi:10.1016/S1097-2765(05)00087-0. PMC 5155437. PMID 11090629.
^ “Klotho converts canonical FGF receptor into a specific receptor for FGF23”. Nature 444 (7120): 770–774. (December 2006). Bibcode: 2006Natur.444..770U. doi:10.1038/nature05315. PMID 17086194.
^ “Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner”. The Journal of Biological Chemistry 275 (11): 7771–7778. (March 2000). doi:10.1074/jbc.275.11.7771. PMID 10713090.
^ “Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins”. Oncogene 10 (8): 1475–1483. (April 1995). PMID 7537362.

[続きの解説]

「線維芽細胞増殖因子受容体1」の続きの解説一覧

線維芽細胞増殖因子受容体1のページへのリンク

線維芽細胞増殖因子受容体1とは？わかりやすく解説

線維芽細胞増殖因子受容体1

「線維芽細胞増殖因子受容体1」の関連用語

線維芽細胞増殖因子受容体1とは？ わかりやすく解説

線維芽細胞増殖因子受容体1

急上昇のことば

「線維芽細胞増殖因子受容体1」の関連用語

線維芽細胞増殖因子受容体1とは？わかりやすく解説